ID

24169

Beschreibung

Study ID: 100577 Clinical Study ID: 100577 Study Title: Double-blind, randomized study to evaluate the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 6 month schedule in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289757 https://clinicaltrials.gov/ct2/show/NCT00289757 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A Documentation part: Tracking Document, Long Term Follow-up

Link

https://clinicaltrials.gov/ct2/show/NCT00289757

Stichworte

  1. 27.07.17 27.07.17 -
Hochgeladen am

27. Juli 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine Serious Long Term Follow-up 100577

Long Term Follow-up Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 100577

Long Term Follow-up
Beschreibung

Long Term Follow-up

Alias
UMLS CUI-1
C1517942 (Long-term Follow-up)
UMLS CUI-2
C0170300 (Hepatitis A Vaccines)
SNOMED
871751006
Subject number of previous study
Beschreibung

Subject number of previous study

Datentyp

text

Alias
UMLS CUI [1,1]
C2348585 (Clinical Trial Subject Unique Identifier)
UMLS CUI [1,2]
C2242969 (clinical trial participant (history))
Subject initials
Beschreibung

Subject initials

Datentyp

text

Alias
UMLS CUI [1,1]
C2986440 (Person Initials)
UMLS CUI [1,2]
C0681850 (Study Subject)
Date of birth
Beschreibung

Date of birth

Datentyp

date

Alias
UMLS CUI [1]
C0421451 (Patient date of birth)
SNOMED
184099003
LOINC
LP57552-9
Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
Beschreibung

long-term follow-up study participation

Datentyp

integer

Alias
UMLS CUI [1,1]
C2348568 (Study Subject Participation Status)
UMLS CUI [1,2]
C1517942 (Long-term Follow-up)
UMLS CUI [1,3]
C0170300 (Hepatitis A Vaccines)
SNOMED
871751006
Subject eligible but not willing to participate due to:
Beschreibung

long-term follow-up study participation

Datentyp

integer

Alias
UMLS CUI [1,1]
C2348568 (Study Subject Participation Status)
UMLS CUI [1,2]
C1517942 (Long-term Follow-up)
UMLS CUI [1,3]
C0170300 (Hepatitis A Vaccines)
SNOMED
871751006
If adverse events, or serious adverse event, please specify
Beschreibung

Subject eligible but not willing to participate due to

Datentyp

text

Alias
UMLS CUI [1]
C0877248 (Adverse event)
LOINC
MTHU014542
UMLS CUI [2,1]
C2348568 (Study Subject Participation Status)
UMLS CUI [2,2]
C1517942 (Long-term Follow-up)
UMLS CUI [2,3]
C0170300 (Hepatitis A Vaccines)
SNOMED
871751006
If Other, please specify
Beschreibung

Subject eligible but not willing to participate due to

Datentyp

text

Alias
UMLS CUI [1,1]
C2348568 (Study Subject Participation Status)
UMLS CUI [1,2]
C1517942 (Long-term Follow-up)
UMLS CUI [1,3]
C0170300 (Hepatitis A Vaccines)
SNOMED
871751006
Investigator signature
Beschreibung

Investigator signature

Datentyp

text

Alias
UMLS CUI [1]
C2346576 (Investigator Signature)
Investigator signature date
Beschreibung

Investigator signature date

Datentyp

date

Alias
UMLS CUI [1,1]
C2346576 (Investigator Signature)
UMLS CUI [1,2]
C0011008 (Date in time)
SNOMED
410671006

Ähnliche Modelle

Long Term Follow-up Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 100577

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Long Term Follow-up
C1517942 (UMLS CUI-1)
C0170300 (UMLS CUI-2)
Subject number of previous study
Item
Subject number of previous study
text
C2348585 (UMLS CUI [1,1])
C2242969 (UMLS CUI [1,2])
Subject initials
Item
Subject initials
text
C2986440 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
integer
C2348568 (UMLS CUI [1,1])
C1517942 (UMLS CUI [1,2])
C0170300 (UMLS CUI [1,3])
Code List
Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
CL Item
Subject not eligible (1)
CL Item
Subject lost to follow-up or not reached  (2)
CL Item
Subject eligible but not willing to participate due to: (3)
CL Item
Subject eligible and agreed to participate in the long-term follow-up study (4)
Item
Subject eligible but not willing to participate due to:
integer
C2348568 (UMLS CUI [1,1])
C1517942 (UMLS CUI [1,2])
C0170300 (UMLS CUI [1,3])
Code List
Subject eligible but not willing to participate due to:
CL Item
adverse events, or serious adverse event (1)
CL Item
Other (2)
long-term follow-up study participation
Item
If adverse events, or serious adverse event, please specify
text
C0877248 (UMLS CUI [1])
C2348568 (UMLS CUI [2,1])
C1517942 (UMLS CUI [2,2])
C0170300 (UMLS CUI [2,3])
long-term follow-up study participation
Item
If Other, please specify
text
C2348568 (UMLS CUI [1,1])
C1517942 (UMLS CUI [1,2])
C0170300 (UMLS CUI [1,3])
Investigator signature
Item
Investigator signature
text
C2346576 (UMLS CUI [1])
Investigator signature date
Item
Investigator signature date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video